(OABI) OmniAb - Performance -50.8% in 12m
OABI performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-77.27%
#122 in Peer-Group
Rel. Strength
9.21%
#6968 in Stock-Universe
Total Return 12m
-50.77%
#128 in Peer-Group
Total Return 5y
-80.23%
#93 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 4.84 USD |
| 52 Week Low | 1.25 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 96.80 |
| Buy/Sell Signal +-5 | 1.38 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: OABI (-50.8%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
0.07% | 70.8% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.72% | -1.16% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
2.97% | -9.23% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
15% | 42% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-5.87% | 54.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: OABI vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for OABI
| Total Return (including Dividends) | OABI | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 28.67% | 3.36% | 4.68% |
| 3 Months | -7.66% | 15.73% | 24.35% |
| 12 Months | -50.77% | -7.02% | 14.02% |
| 5 Years | -80.23% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | OABI | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 72.3% | 4.4% | 81% |
| 3 Months | -44% | 78.8% | 96.9% |
| 12 Months | -93.2% | -85.8% | 44.9% |
| 5 Years | -70.6% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th93.00 | 27.18% | 22.91% |
| 3 Month | %th20.50 | -20.93% | -25.74% |
| 12 Month | %th36.00 | -46.17% | -56.82% |
| 5 Years | %th55.50 | -70.89% | -87.14% |
FAQs
Does OmniAb (OABI) outperform the market?
No,
over the last 12 months OABI made -50.77%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months OABI made -7.66%, while XBI made 15.73%.
Performance Comparison OABI vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
OABI vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 9.7% | 24% | -53.6% | -65% |
| US NASDAQ 100 | QQQ | 10.1% | 23.6% | -54.3% | -63% |
| German DAX 40 | DAX | 11.4% | 30.1% | -65.8% | -80% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 10.2% | 25.3% | -57.1% | -71% |
| Hongkong Hang Seng | HSI | 9.4% | 23.3% | -73.1% | -92% |
| India NIFTY 50 | INDA | 10.7% | 27.1% | -54% | -50% |
| Brasil Bovespa | EWZ | 9.3% | 21% | -78.7% | -61% |
OABI vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 10.6% | 22.8% | -57.8% | -75% |
| Consumer Discretionary | XLY | 9.7% | 25.5% | -46% | -69% |
| Consumer Staples | XLP | 8.9% | 28% | -55.3% | -60% |
| Energy | XLE | 8.9% | 21.6% | -49.5% | -51% |
| Financial | XLF | 8.5% | 23.6% | -58.6% | -81% |
| Health Care | XLV | 9.8% | 26.5% | -46.3% | -46% |
| Industrial | XLI | 9.1% | 24.5% | -61.5% | -76% |
| Materials | XLB | 7% | 24.4% | -58.2% | -57% |
| Real Estate | XLRE | 9.3% | 27.7% | -53.4% | -64% |
| Technology | XLK | 8.5% | 20% | -56% | -62% |
| Utilities | XLU | 10.3% | 26.9% | -56.9% | -74% |
| Aerospace & Defense | XAR | 11.3% | 21.6% | -72.2% | -100% |
| Biotech | XBI | 8.2% | 25.3% | -40.4% | -44% |
| Homebuilder | XHB | 6.7% | 21.7% | -46.5% | -56% |
| Retail | XRT | 6.7% | 23.7% | -49.3% | -62% |
OABI vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 8.3% | 20.2% | -45.3% | -43% |
| Natural Gas | UNG | 18.7% | 38.5% | -36.9% | -49% |
| Gold | GLD | 10.2% | 28% | -74.3% | -92% |
| Silver | SLV | 8.2% | 21.8% | -71% | -68% |
| Copper | CPER | 10.1% | 23.1% | -70.7% | -63% |
OABI vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 11% | 27.6% | -50.2% | -49% |
| iShares High Yield Corp. Bond | HYG | 10.8% | 26.8% | -52.5% | -61% |